GeneDx
Sharon Konspore is an experienced finance professional currently serving as Senior Manager of FP&A and Treasury at GeneDx since October 2017, contributing to advancements in personalized health insights through genomic data analysis. Concurrently, Sharon holds the position of Senior Manager in Finance at Sema4, a health information company aimed at enhancing disease diagnosis and treatment. Prior to these roles, Sharon worked at Robert Half from March 2011 to October 2017 as a Financial Specialist, providing consulting services across various organizations. Sharon's diverse experience includes positions such as Accounting Manager at Ring2Media, where all finance and accounting functions were managed, and various temporary roles in financial services through Robert Half. Sharon holds a Bachelor of Science in Business Administration with concentrations in Accounting and Forensic Accounting from Franklin Pierce University.
This person is not in any teams
This person is not in any offices
GeneDx
10 followers
GeneDx is focused on delivering personalized, actionable insights that improve health outcomes. We sit at the intersection of diagnostics and data science, pairing decades of genomic expertise with an unmatched ability to interpret clinical data at scale. Our exome and genome testing is among the best in the industry. We expect that it will be even more advanced in the future with the help of Centrellis®, our innovative health information platform. Powered by millions of medical records, Centrellis® integrates digital tools with artificial intelligence to ingest and synthesize clinical and genomic data. As a result of our robust test menu, including our exome and genome testing, and the comprehensive insights generated by Centrellis®, we are developing a more complete understanding of complex disease than ever before. This translates to faster diagnosis, more effective treatment plans, and enhanced drug discovery. Our offerings help a whole spectrum of healthcare partners -- clinicians, researchers, health systems, pharmaceutical companies, and payors -- improve patient experiences and advance population health.